MET and neoplasm: Altogether, these results confirm that all K and KM non‐regressed tumours that presented an amplification on chromosome 6 are addicted to cMet, since treatment with Tepotinib led to tumour regression by decreasing proliferation and inducing apoptosis, confirming that cMet is essential for the proliferation and/or viability of tumour cells.